sentiment are now -- traders in energy >> a record high for -- >> almost a multiyear high in schlumberger right there >> all right, thank you for joining us, chris. thank you for watchin in"ft g as money. "mad money" if you're going to speak stocks you need a healthy amount of skepticism. you can't enough to the point of

corrosion but the need to believe in something otherwise, you'll miss out on amazing opportunities this market affords you and saw some play out even as the averages were not so hot. those were well off the lows and i think we have a big problem here on wall street. that's where i'm located right now, wall street but simply most people don't trust the market anymore they don't ceos. they don't trust individual companies. just endless skepticism and little sincere belief. i'm playing around a whole series on why we lost faith in the market most people have given up on owning pieces of individual companies, a lot goes down to the fact that day-to-day action doesn't make sense trying to gain things. not showing up or downs for reasons that have nothing to do with underlying companies. but there are moments when the

market works like it's supposed to i have two nondysfunctional examples most highly gettable. i know that because we own them for my trust eli lilly had a tremendous quarter. it could be the biggest drug of all time i believe when all is said and done we'll find out that it can help you shed about 18% of your weight it can lower your blood pressure and it can even stop heavy drinking one shot once a week, what a miracle. truly phenomenal we also got data from novo nordisk, the competitor with wegovy or ozempic and might be a

matter of time because a huge chunk of the population has its life altered by this i think the health insurers and medicare will come around to pay for them because they are that life saving. in response the numbers and the possible action eli lille jumped nearly 15% and makes sense and have one of the best-selling drugs in history, 15% gain is too small. maybe it should have been 25%. either way this company is worth a heck of a lot more today than yesterday but didn't have this incredibly positive new information. you invent an amazing new product and sells like crazy then your stock soars. that's perfectly passable action the other side of the trade makes defense too. the medical devices saw their stocks sell off and will have less business if litlly's shot

does perfectly logical that they're selling off because there's so many things that this can do right. second example, does it make sense nvidia is the number one performing stock of the year on the s&p 500? of course, it does this company makes semiconductors that were previously only used to give you the best graphics. cool business but not enough to justify $1.1 trillion market cap but then we found out the new chips are the background of artificial intelligence and nobody else comes close. their ceo showed you high bundles of high-end semiconductors talk directly to a machine and have it generate amazing ideas using artificial intelligence you can't have by yourself you don't need caltech to use it just talk. tell it you want to make a plant and the machine does pretty much everything else because it can

generate inferred intelligence it has digital robotics that renders the plan on its own and make adjustments also by talking to the machine a lot more space for workers, you get. then take their design and build its giant digital twin, the factory itself on a million dollar facility built with old equipment could be replaced with $8 million in their new technology with 20 times the last power used. the largest market in the world by far is the manufacturing market especially the factory building side of the equation. i watched the video of jensen wrap if used effectively it could revolutionize the entire manufacturing economy. as he tells it, the more chips you buy the more you'll save on your business. no wonder is the year's biggest

winner find me another company that can impact $50 trillion in heavy industry when you look at it through that lens nvidia deserves this valuation. the probably is probably too low if anything. the other side, given a.i. dominance stands to reason you might want to pay less for other semico semiconductors that doesn't have to happen today. see, you need to think twice in jensen is right and i have no doubt, no reason to doubt the word of the man because he's a renaissance man, never steered me wrong now that our other companies that reported admitted weak earnings makes sense. data dog came in with sky high expectations, so high we got a growth forecast that was not great and plunged 17%.

i want to get it correct and you should be in individual stocks so why can't we just find the eli lilly or nvidia and own them we can and we did. i hounded you on these but many were scared away by bad press. we saw tons of stories about how it would be a fad, not true. we heard suicidal ideation, hey, so does life all these stories came from this fantastic stock and stuck with it in the investing club and did our homework nvidia why do so few people i know own it did they not listen to my endless multiyear pan to the man and myth >> noment many were misled by the past and couldn't believe a gaming company would be able to stand up to, say, intel. they thought the whole thing was too pie in the sky to be credible and chose thought to

believe and missed out on two of the most biggest ones i've ever seen keep our eyes and ears open as long as you suspend your crept cal overly critical self and realize that sometimes they invent amazing things that generate trillions of dollars as well and claim your fair share but only if you are willing to believe. chris in new jersey, chris >> caller: hey, jim, a big garden state boo-yah from me and my daughter olivia. >> olivia, how can i help? >> caller: i was calling nee, ticker symbol. my father picked it up for me and sitting on a great dividend yield. they increased dividends 10% annually it's been declining last year. should i pay puts and -- >> i want you to stay put. not my favorite. look, i like ambridge but i

would not have you sell nextera down here. it's too low it's not great but i think it's too low. james in new york. james. >> caller: boo-yah, jimmy. what's going on. >> you come to play, i like that i want people come to play >> caller: i've been following you since back in the '90s love the show. awesome, man also, great piece on the sbc i love the fact that you tell it like it is >> i sure try. thank you. thank you. >> caller: all right i have a question. we bought palo alto. obviously, you know, it went down and with the downgrade too but i have a question about it >> sure. >> caller: maybe palo alto said they'll record ten days from

now. it's a friday afternoon in the summer at 4:00 we started our weekend and you -- >> i don't like they're doing it i agree with you i know he's got to do a lot of one-on-one meetings and will lay out a very long plan i wisher not recording on that friday and i think it's scaring people and the shorts are ganging up trying to knock it down all because of that friday deadline it is a shame because i think the company has a three-year outlook and that will be worst owning claim some of the weather of these great companies but only if you're willing to believe and i'm going to try to get you to believe. on "mad money" tonight, a shake-up and i'm learning what the deal means from you. then restaurant brands international, that's the company like burger king reported unexpected results so why did the stock not do it?

i'll get to the bottom of that and from weight loss to alzheimer's eli lilly has several key treatments and i'm learning more what's in the pipeline at the top of the show when we speak to the ceo so stay with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter have a question, tweet cramer, #madtweets send jim an email to madmoney@cnbc.com or give us a call at 1-800-743-cnbc miss something, head to madmoney.cnbc.com.

bridgett is here. she has no clue that i'm here. she has no clue who's in the helmet. are you ready? -i'm ready! alright. xfinity rewards creates experiences big and small, and once-in-a-lifetime.

back in the '80s we didn't

talk about pipelines we don't have enough infrastructure to get it from where it's produced. usually the middle of nowhere. that's why i've always got an eye on the pipeline place and something interesting happened back in may when we learned one oaks buyed magellan midstream partners for 18.8 billion in cash and stock, 22% premium from where they previously traded and both said there could be $204 million of annual synergy from the deal and big contribution could be coming. i have been fond of both because magellan is a publicly traded partnership, while one oak is the sea corp there are complicated tax consequences which some of the shareholders have said they're voting against the merger they say their investors will only pay new taxes from the takeover premium and a lot more to be had. they point out the timing of one of the deals is advantageous

because the taxed owed by magellan's union holders are likely to increase soon. if it continues as an independent entity, i know it's complicated which is why i want to take a closer look at aaron, the president and ceo of magellan midstream and have to talk to what's happening to the union and the deal welcome in >> thanks for having me. >> well, i want people to understand this combination is a powerful one and that i have -- people should be shifting from traditional electric utilities that are yielding 3% to 4% to consistent pipeline companies that aren't as levered to a commodity as you think why don't you talk us through the new one. >> the combined company is going to be exciting it will have refined products, transportation of things like moving gasoline, diesel jet fuel and moving crude oil from places like the permian base and moving

natural gas liquids and natural gas so you'll have a company with all of those commodities and fee-based business to your point. >> people may say, well, wait a second if oil is going down and natural gas is going down then the distribution will go down. it's quite the opposite. it just -- that's not the way these companies work at all. >> no, we're a volume business and as long as the products are demanded and needed we'll make more money so as the commodity price moves around, as long as it's needed we'll tinge to move it and do quite well. >> one side i think and i followed one oak because of the cfo from summit new jersey has usl & g transport. >> exports are an important story for the u.s. energy complex. you know, we need the energy here in the united states and focused on that but the fact is the world needs the energy as well so we're going to be continuing to export more and more refined

products, crude oil, natural gas liquids out of this country for a very long time because the world needs the nuclear reactor. >> people don't seem to understand we are short oil pipelines and don't have enough. magellan has the best. >> we think we have the best. >> i know you do i've studied this a long time. >> and, right, at this moment i think we may have enough oil pipelines to corporation and is probably okay but as drilling continues to increase we'll need more infrastructure. >> absolutely. >> the demand snths going away whether in the united states or in the world. >> one issue i've been reluctant to tackle is what will happen to people's personal taxes. that is very much to be decided between a person and their accountant at the same time, though, when it comes to a deal maybe not going through because of taxes, i have to just bring up what happens to someone who has been a longtime holder of magellan and this deal goes through. >> it's a good question. what we have to focus on is the value that we're creating.

this deal that we're -- we have with one oke represents a full value for magellan a funnel value and a value that, frankly, will be difficult for us to replicate stangealone. >> it's a full value on the way in and look at the combined company and talked about it and we've seen the resilience and diversification in the combined company and put those together it's a really powerful value proposition so that's where you have to start, that value proposition. >> okay. >> once we understand that now let's talk about taxes you know, as you know, taxes are a deferred investment, not tax-free eventually the taxes are going to come due. >> right. >> the question is, do you want more which we think the transaction provides more or you want less but you're paying taxes anyway >> when you add the premium in it's very difficult to see why someone wouldn't want the

premium then eventually have to pay taxes no matter what. >> you're paying taxes either way. go back to before we announced this deal. magellan trading at $55.41 we announced the transaction and have the potential for $67.50 on the table based on the terms at the time the value of the companies. it's traded as high as $70 recently in terms of what our holders see so you want 55 or 70 you're paying the taxes on both sides. >> i don't think people realize this from the previous regime we have a government that is not necessarily pro -- it's not like the government is trying to make more money for you of that's not been the case. >> no, infrastructure has been difficult. >> yeah. >> of late >> you're a gentleman. >> infrastructure has been difficult. but you bring up a good point in the sense that it's absolutely required if we want to benefit from the resources we have in this country we'll have to have

infrastructure to do it. that's what this combined company will more powerfully provide than we can do by ourselves is that infrastructure so that we can enjoy the resources we have in this country. >> i can't own individual stocks but as someone who always loved the mlps in the old days when i could this deal is just a major win and i think people frankly don't understand the economics of a great deal. >> the combined company is exciting and, yes, you have to pay the taxes but you owe them anyway. >> that's aaron milford, ceo and magellan mmp i like the trust and one oke is such a great company back after this. >> announcer: coming up, ticker symbol qsr has a lot on its plate. save room for dessert. cramer's got the top chef next

new nature's bounty hair growth. clinically shown to help grow thicker, fuller hair with just one capsule a day of advanced hair complex. conquer hair thinning... ...and fall in love with your hair all over again. only from nature's bounty.

what's it going to take restaurant brands international to make its next move higher i've been recommending the parent of burger king, tim hortons, popeyes and firehouse subs late last year when they brought in patty doyle, former ceo of domino's. worked out pretty well with the stock up nearly 25% since doyle came on board. restaurant brand stock has been trading sideways for the last few months i thought that would change when the company reported yet another stellar quarter today. oh, it was stellar 9.6% same-store sales growth is big and eight-cents earnings beat and opening up nearly 3% it finished day down slightly which frankly given the numbers is nuts i spoke with the executive chairman of restaurant brands international to learn more. take a look.

mr. doyle, welcome back to "mad money. >> hey, jim, how are you >> i'm good, pat how are you? >> i'm feeling great i got to tell you you're feeling great but on the conference cail, the call before you got on, all very positive then you come on and just point blank say that your numbers are not what you aspire to. so tell us how you did and tell us how you can do better >> yeah, it was a great quarter overall. ebitda up 10%. tim's is doing incredibly well, comps 12 1/2 burger king in the u.s. up high single digits, 8.3, i think. international had a terrific quarter. overall great. you know, when i said that, you know, we aren't quite there yet, less growth and we need more we're about 4% yore over year and said on the call i'm confident we'll get to 5 plus%

restaurant growth next year and going forward and that's a big area we have to work on. >> what does it take i would want a franchise and buy a master franchise with those numbers. the payback has to be pretty swift. >> payback is good, particularly the international businesses are doing great. as we continue to focus on, you know, the returns that the restaurant levels, i'm confident we'll get that restaurant store count growth going in the right direction. no higher than it is right now. >> i don't want to dwell too much on popeyes but ui love the chain and i know you spent a lot of time on it and i know that the year before this company was bought, it had 7% comps and a lot of that was because they had kind of a new thing every month, are we going to see something like that because i've got to tell you i know you're making some changes and i know that

it's more have it your way than ever before but i know the numbers aren't what you like. >> i think they were a little o over 4% domestically system sales are double roughly what they were when we bought it at the end of 2017 so have made great progress with the business blackened chicken sandwiches are out. our ghost pepper wings are terrific those are new products we've introduced we'll get it going the right way. i think the one thing we've got to work on with popeyes in addition to continuing to roll out some great new products is we've just got to make it a little bit easier to run which will give faster service a little slow versus where it needs to be but things we're working on that i think will speed that up and generate good growth. >> i want to talk about tim hortons. the numbers are extraordinary. you -- if starbucks were here, they would be saying, i can't

believe the numbers but you talk about how it's not doing well enough in the evening. what can you do? >> evening grew a lot. i mean, evening grew, you know, i think 15% plus in the second quarter, so it's making great progress, but, you know, still more to work on. overall tim is up 12.5% given the scale of the business, order growth, we're continuing to grow in cold beverage that's now 40% of our beverage sales, so overall, absolutely going the right way, i guess without a highlight, we still see lots of upside, lots of areas we continue to grow this business to me it's all about the opportunity. >> understood. now, how about how are you capturing younger people you have a good marketing plan just in the time since i've known you from popeyes we've had

the market different but where are you reaching people? >> yeah, so it's about a few things so first of all, it's about reinvesting from the company standpoint we're reinvesting in advertising, just to give the more -- the bran more presence. i think we're seeing some really nice momentum starting to build from that in the second quarter and following from late last year, we've had good growth in that business. we're getting the franchisees' profitability to a better place. the last bigger longer-term thing we have to work on is we've got a little less than half of our restaurants in a new image today. we've got to fix that, right they've all got to look great but we're partnering with our franchisees to do that over time we're going to have a brand that looks as good as the food is. >> how does the european stores

look i've been to a couple. they look great to me but i see france, australia, spain happy what's going on? >> yeah, i think that the business outside of the u.s., system sales for burger king for the quarter were over 4 billion and they were up 18.5% i mean, just unbelievable growth in that business and to me that's the bottle, right great-looking store, more digital than we are in the u.s., the food is terrific like it is in the u.s. so, i really think that the model is there if we can get the assets looking -- the restaurants looking as good as they do internationally in the u.s., get a little more aggressive with the use of digital, i think we're absolutely going to get there on the domestic side as well >> let me ask the toughest question when i see how you're doing and you just described and i know what you're doing at tim hortons and see the progress at popeyes i say why does pat doyle worry

about firehouse subs why not let that go and say, listen, the big money is being made in the other chains >> yeah, i mean, look, it is relatively small compared to the others here's the upside. sandwich category is terrific and growing. big opportunity there domestically outside of the u.s. there's really only one player, subway so we just launched our first store outside of north america in switzerland it's doing congratulate. we're signing deals with franchisees around the world many already within our system who are looking for an entrance into the sandwich category we're there before jersey mike's and before gym economy john's. we've simply got a real opportunity to build a big business outside of the u.s. and great growth opportunities domestically as well. >> look, i have to tell you, you are so difficult to satisfy and that's one of the reasons we like restaurant brands

international so much. i want to thank patrick doyle, restaurant brands executive chaim and these are great numbers. pat, congratulations >> thank you are, jim. i appreciate it. "mad money" is back after the break. >> announcer: coming up, eli lilly floored on strong earnings cramer digs into the lab results with the company's top brass next (vo) antarctica... you have to experience it to truly appreciate the beauty, the wildlife, the sheer majesty. experience it with state-of-the-art expedition equipment and hands-on scientific research activities, all in exceptional viking comfort. we invite you to discover the world's

seventh continent: antarctica. viking. exploring the world in comfort. my cpa told me i wouldn't qualify for the erc tax refund, so i called innovation refunds. their team of independent tax attorneys will work with your cpa to determine if your company is eligible. [whip sound] take the first step to see if your small business qualifies.

- [soldier] take a look at this! take the first step to see if - they've left us a gift. - [soldier] i think we misjudged them. - i love horses. (birds chirping) - [soldier] we should open the gate. - let's see what charlotte thinks. - [narrator] at crowdstrike, we monitor trillions of cyber events to detect threats and prevent breaches before they happen to keep your business from becoming history. we stop cyberattacks. we stop breaches. we stop a lot of bad things from happening. crowdstrike. protection that powers you.

even bad days can be great for your portfolio if you own the right stocks today was off the averages but shareholders in eli lilly including my charitable trust

don't feel that way. the big titan saw a spike of 15%. now, how do you get this action and move them into the largest health care company, you have another excellent quarter, big earnings beat management and raised full year forecasts substantially and lilly has mounjaro and likely to receive fda approval maybe as a weight loss pill that belongs in the same class of drugs as novo nordisk's mounjaro it means mounjaro could have wide-ranging means it is in a shot form so let's check in with dave rick, chairman and ceo of eli lilly to get a better read on

the quarterly and mounjaro welcome back. >> thanks, jim great to be with you. >> you have on your hands incredible drugs we've got to talk about mounjaro first. you're dealing with a drug that is doing unbelievable things for diabetics and maybe one day could do something for weight loss for blood pressure for people who drink too much. for sleep apnea. i think our viewers want to know, first of all, how it's been for diabetes and, second of all, how could it possibly do so many other good things for a person's body? >> it really is an amazing medicine that has a chance to reach tens of millions in the country and beyond, and affect their health and how they feel every day and maybe extend life and just learning about the benefits today as you note an important study looking at cardiovascular benefits in people who don't have diabetes. we know these drugs improve card

soos cue lahr outcomes and mortality risks. it can help people without diabetes who are obese our drug, mounjaro, is currently approved in type 2 diabetes, i get stories every day, jim, letters from patients who are -- their life is being changed and glucose under control and coming off other medications and losing lots of weight and feel better we know we can affect obesity as well that's under review at the fda now and expect to prove it by the end of the year. what we need to find out next by affecting weight in people without diabetes can we reduce other risk factors in health, those studies are under way and we'll be rolling out as early as '24. >> this is one of the few drugs i've seen where frankly there isn't enough of it i understand you have a new facility that just opened but if everything works out we're dealing with a drug that may be given to so far in excess of what you can produce right now what is eli lilly doing to pete demand >> yeah, thank you for that

question because it's my top priority is expanding the capacity of our ability to make not just mounjaro but other drugs like it in our pipeline to meet the challenge here, which is a great opportunity, as well, of course, people are frustrated when they can't get their medicine we understand and will fix that problem. today we announced two things important. one you mentioned our new very large factory which we just built in north carolina and research triangle opened and it's producing a commercial product now, so now we begin a new sort of ramp we said last year that by december, our monthly output will be about double what we did last year so this facility is key to put us on that path we also announced two other important actions which is we will be launching mounjaro in a vial where there is a lot of capacity in the world to make vials of medicine as well as a multiuse pen we currently use for another diabetes product which we've repurposed and

re-engineered for mounjaro this will allow us to launch five u.s. enabling opportunities in those markets and people to benefit from the drugs there but taking off pressure off u.s. u.s. supply from the global demand so i think all three actions will help in the midterm. that said, what you're mentioning is important. probably last year around the world, 10, 12 "people (the tv show!)" used this class of drugs for diabetes there's almost a billion people who could benefit from obesity medications according to the w.h.o. by 2045, so we need to do a lot more and we're planning on doing just that. scaling back producing more factories, but it'll take a little time, but we're committed to that. >> i know you can never predict what medicare will do. what the payers willdo but whe i look at what this drug can do, it attacks at the very core what our health care system has failed at, but more importantly what human nature doesn't allow.

i know people think, you know, health care, well, it's exercise and eating well, you know and i both knows that at the highest level the doctors in this country know it's not true, diet and exercise doesn't work for the vast majority of people who are obese. this is a huge health care issue and i have to believe the payers recognize that diet and exercise just doesn't work for most people >> well, i think we're still in that process, jim, i know you've been active with the brain health issues and our company was a part of the revolution in treating depression in this country with the introduction of prozac and before prozac doctors would say you're just a little sad. we know that's not true and know there's clinical depression and treat it like a disease. we'll think about obesity the same way in five or ten years, we used to say eat better and exercise and will learn a lot need medication to treat and

control their weight over time one study showed in a pretty exquisite way last year. not only did they lose a lot of weight, 22% of their body weight but surprising how poorly the placebo group did because they were on a calorie restricted diet and exercise and average only lost 2 1/2% or 5 pounds over the course of the weeks it's hard to comply with and doesn't work for people who are already overweight so we need this medication to treat a number of diseases you mentioned the study from our competitor next year we have two important studies, one for sleep apnea that will probably be first and i think 7, 8 million use cpap machines and another one for congestive heart failure, the number one reason patients are hospitalized in this country a big problem and driven by

overweight as well so we're attacking that problem by producing the data but need to attack it with what you're raising here destigmatizing this disease. >> so glad you mentioned that, blood pressure much better i know it's taboo to talk about but people drank too much during covid. this is a way to be able to make it so the heavy drinker might have a shot. thank you for mentioning the work that i do with the brain foundation of when i was at -- ran the gala, all people were talking about is the hope the possibility of what you're doing for alzheimer's. where do we stand? >> yeah, great quarter there too. you know, we've been tracking several years our alzheimer's's program investing billions for several decades to get to something that could slow this disease materially and we had a big readout in may with the trailblazer 2 program for donanemab and demonstrated a 35% slowing of the deed, not a cure but that's a very significant slowdown could mean a year or two of

delay in those symptoms progressing. that's more birthday, anniversaries, happy moments with your family important to seniors and important to the health care costs. this disease costs over $200 billion a year to medicare to treat so that happened and that is a replication of a prior smaller study. first time we've had a replication of the drug and biggest effects we have seen we announced we submitted that to the fda and we do expect approval by the end of the year so that's coming very soon. >> well, that's fantastic. congratulations for everybody and how much lilly has done for so many families in this country. that's david rick, chairman and ceo of eli lilly "mad money" is back after the break. >> announcer: coming up, cramer wants to hear from you your calls on the thunderous "lightning round," next.

(fan #1) there ya go! that's what i'm talkin' about! (josh allen) is this your plan to watch the game today? (hero fan) uh, yea. i have to watch my neighbors' nfl sunday ticket. (josh allen) it's not your best plan. but you know what is? myplan from verizon. switch now and they'll give you nfl sunday ticket from youtubetv, on them. (hero fan) this plan is amazing! (josh allen) another amazing plan, backing away from here very slowly. (fan #1) that was josh allen. (fan #2) mmhm. (vo) for a limited time get nfl sunday ticket from youtubetv on us. a $449 value. plus, get a free samsung galaxy s23. only on verizon.

>> announcer: "the lightning round" is sponsored by td ameritrade it is time it's time for "the lightning round. [ buzzer ] >> and then "the lightning round" is over are you ready, skee-daddy? brandon in new jersey. brandon. >> caller: hey, jim. >> you got it. what's going on? >> caller: so i saw insider buying on croc stocks. what do you think? >> i worry about the fact one day it's coming in tee low so i

have to take a pass on it. dave in illinois >> caller: dr. cramer, my mad philly friend. let's fix the debate geno's or -- >> it's always geno's. i'll take you there every day of the week what's happening >> caller: this $20 billion cloud security company is up 75% since its 2022 low and up some 30% so far this year last month you featured this company with others as a third tier cloud company so, jim, i ask your thoughts on zscaler >> dave, i'm worried about microsoft actually going into competition with sscaler and have been partners so i have to say we want to avoid that one, dave same way we have to avoid the bears frankly when it comes to fantasy. sorry. let's go to tony in new york tony

>> caller: hello, jim. how are you? >> tony, i'm good. how about you? >> caller: i'm doing good, jim as you know, the real estate investment trust that owns e. peer enshall properties like movie theaters, water parks and ski centers pays a sweet dividend. >> but i got to tell you they are -- they are un -- they are not worth our trust because now saying they're dishonest but they've been too episodic in the way they report earnings honest guy, episodic number, pass, steve in california, steve. >> caller: jimbo, greatings from sacramento a place that's been in your heart. >> i used to live there but, of course, in my car. very nice neighborhood what's up? >> caller: i'm thoroughly confused by a stock i'm labeling the dog of the dow it's been down ten days in a row after decent earnings, couldn't go higher yesterday with the dow up 400 and can't go higher into

its x dividend date. what is wrong with honeywell >> i am so angry i do this homestretch thing with jeff marks we do it a little after 2:00 he and i went head-to-head i thought it was time to buy we'll hold it until it goes a little lower but i am serious, i think the company has to do something. i haven't felt this way a long time about honeywell i agree with you by we will buy lower once we're able to did so bill in massachusetts. bill >> caller: hi, jim this is bill i'm from massachusetts and not giving you a boo-yah, not a double boo-yah, not a triple boo-yah but a quadruple boo-yah. >> how cani help >> caller: mr. jim, i took 30 seconds to thank you, jim, shawn, your staff is incredible. these young men work so hard and for an older guy like me, i appreciate that. >> thank you.

>> caller: a question on gin -- general dynamics intellectual property and falls on the south china sea i did my homework and found general dynamics, up 17% a year -- >> i think general dynamics is a buy. and i have to tell you, i think the ceo is terrific. it's the right level, 2.3% dividend and i got to tell you, a chart that is next to boston properties is one of the best. gen dymn. can i go to rosana in california. >> caller: hi, jim taking you for taking the call love everything you and jeff do. i'm a member of the investment club >> fantastic we get some right. how can i help >> caller: yes, i'm wondering about a medical stock i just

came across that seems to be doing well it is near its 52-week high. >> okay. >> caller: cbx. >> they are such a well run company. i wish we owned that for the club ladies and gentlemen, that's the conclusion of "the lightning round. [ buzzer ] >> announcer: "the lightning round" is sponsored by td ameritrade it's an entire trading experience. with innovation that lets you customize interfaces, charts and orders to your style of trading. personalized education to expand your perspective. and a dedicated trade desk of expert-level support. that will push you to be even better. and just might change how you trade—forever. because once you experience thinkorswim® by td ameritrade ♪♪♪ there's no going back. how's the chicken? the prawns are delicious. oh, i have a shellfish allergy. one prawn. very good. did i say chicken wrong? tired of people not listening to what you want? it's truffle season! ah that's okay...

never enough truffles. how much are they? it's a lot. oh okay - i'm good, that - it's like a priceless piece of art. enjoy. or when they sell you what they want? yeah. the more we understand you, the better we can help you. that's what u.s. bank is for. huge relief. yeah... ♪

we keep hearing how short

sellers are being crushed by the market i say they're crushing themselves because so much of this pain is self-inflicted. >> the house of pain. >> they stayed short too long once again and got hair heads handed to them justifiably wayfair, now it's obviously why people -- they sell furniture and know went out of style when the pandemic ended causing consumers to stop spending on hard goods and spend it on travel and leisure last year you could have made a killing but to keep shorting it now when the economy is going in the right direction, just pure idiocy bulls make money, bears make money but pig, guess what, slaughtered. people continue to short wayfair fall into that category and now the other white meat i feel the same way about carvana. this is like gamestop which plunged to below $5 before ex-employeding to $400 on the

stop of the craze. what were they thinking? that it had to go under? that it had to declare bankruptcy imbeciles. it isn't like the old days but a market with rabid traders eager to crush short sellers and can make a short squeeze and send lousy stocks soaring how could they learn their lesson honestly, if the short sellers had been less greedy maybe the meme sters would never have come to carvana's rescue. the company was able to raise a bunch of money and clean up its balance sheet just like wayfair, the shorts are now pork products the real estate trust, the ceo of tatanger outlets real estate investment trusts were way out of favor and said he has a booming set of

properties which are destination places for families when the weather is not so hot on the weekend. they're filled and leases going for a ton of money huge number of short sellers in the name, though, eager to bet against retail and real estate investment trusts while the shorts got smoked as the stocks now at $25, it is a 52-week high i have a dozen of these -- oh, make it two dozen. these short positions and so many others were predicated on the idea that the economy was falling apart. those were what i call theoretical shorts where you were helpless if it turns out to be wrong and didn't go into recession. the real lesson if you're negative and stay negative when it's clear that the economic situation has changed, you have to declare either victory or defeat and move on go away. either way let me tell you something, the battle is over. you can't bet against the stock because of recession fears then keep betting against it when the

fears evaporate. you can't hope for your own outcome to the point where you ignore reality that is and will always be a fool's game. i like to say there's always a bull market conspiracy i promise to find it right here for you on "mad money." magic kingdom going for broke. espn one of the biggest casino operators joining forces and we will have the breaking developments. energy transition interrupted. why are so many stocks bleeding red? twitter, excuse me, x. elon musk opening the cap on ad revenue sharing. a waiting game. when will chipmakers get the long-awaited windfall? a bourbon boom. southern investors are finding liquid goal by the barrel.